Iron ranks 141 of 351 Prostate cancer treatments based on 7 research articles we have analyzed from 164 relevant articles we identified. The relationship is in the bottom 3% of our analyses.

About Iron and Prostate cancer

Prostate cancer, also known as carcinoma of the prostate, is the development of cancer in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, some grow relatively fast. The cancer cells may spread from the prostate to other parts of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages it can cause difficulty urinating, blood in the urine, or pain in the pelvis, back or when urinating. A disease known as benign prostatic hyperplasia may produce similar symptoms. Other late symptoms may include feeling tired due to low levels of red blood cells.1

Iron is a chemical element with symbol Fe (from Latin: ferrum) and atomic number 26. It is a metal in the first transition series. It is by mass the most common element on Earth, forming much of Earth's outer and inner core. It is the fourth most common element in the Earth's crust. Its abundance in rocky planets like Earth is due to its abundant production by fusion in high-mass stars, where the production of nickel-56 (which decays to the most common isotope of iron) is the last nuclear fusion reaction that is exothermic. Consequently, radioactive nickel is the last element to be produced before the violent collapse of a supernova scatters precursor radionuclide of iron into space.2

There have been 67,569 reported side effects for Iron in the US. The 5 most reported: Nausea, Dyspnoea, Anaemia, Diarrhoea, Fatigue.

The average price we found for Iron products was $40.67. The lowest price we found was $12.35

What researchers say about Iron as Prostate cancer treatment

Researchers report:

  • To compare the nodal risk formula (NRF) as a predictor for lymph node (LN) metastasis in patients with [Prostate cancer] with magnetic resonance lymphography (MRL) using Ultrasmall Super-Paramagnetic particles of [Iron] Oxide (USPIO) and with histology as gold standard.1
  • Biotinylated anti-PSMA antibody was conjugated to streptavidin-labeled [Iron] oxide nanoparticles and used in MR imaging and confocal laser scanning microscopic imaging studies using LNCaP [Prostate cancer] cells.2
  • The finding that HO-1 expression is increased in BPH and malignant prostate tissue is consistent with a role for this stress protein in the pathogenesis of BPH and [Prostate cancer]; in the context of [Iron] metabolism, an argument is made in support of this possibility.3
  • We report the synthesis of superparamagnetic [Iron] platinum nanoparticles (SIPPs) and subsequent encapsulation using PEGylated phospholipids to create stealth immunomicelles (DSPE-SIPPs) that can be specifically targeted to human [Prostate cancer] cell lines and detected using both MRI and fluorescence imaging.4
  • The purpose of this study was to investigate the feasibility and optimization of protocols using superparamagnetic [Iron] oxide (SPIO) nanoparticles to label human [Prostate cancer] cell lines PC3 in vitro.5

Review all research

More Prostate cancer treatments

Explore all Prostate cancer treatments we have analyzed:

9696% Complete
9494% Complete
9393% Complete
Abiraterone acetate
9090% Complete
9090% Complete
8686% Complete
8686% Complete
7878% Complete
6666% Complete
6666% Complete

All Prostate cancer Treatments 351

Get updates on Iron as Prostate cancer treatment

Subscribe to receive notifications by email.


Research last analyzed March 03, 2015 @8:55AM.